Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy

IntroductionDecline in kidney function due to renal fibrosis is a potential side effect in patients with neuroendocrine neoplasm (NEN) undergoing Peptide Receptor Radionuclide Therapy (PRRT). We aimed to investigate the potential of circulating fibrosis markers reflecting formation and degradation o...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Tobias Stemann Lau, Lars Bossen, Daniel Guldager Kring Rasmussen, Federica Genovese, Morten Karsdal, Anne Kirstine Arveschoug, Henning Grønbæk, Gitte Dam
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2025-06-01
Σειρά:	Frontiers in Endocrinology
Θέματα:	PRRT fibrosis markers biomarkers neuroendocrine neoplasms neuroendocrine tumors kidney fibrosis
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1495369/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!